Since 1 March 2022, pursuant to Article 30 of Regulation (EU) 2022/123 of the European Parliament and of the Council [Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (OJ L 20, 31.1.2022, p. 1, ELI: http://data.europa.eu/eli/reg/2022/123/oj).], the European Medicines Agency, on behalf of the Commission, provides the secretariat for the expert panels designated in accordance with Article 106(1) of Regulation (EU) 2017/745. Implementing Decision (EU) 2019/1396 should therefore be amended to reflect that change.
Recital 3, Decision_act (EU) 2025/1324
In forcesince 7 Jul 2025